Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-κB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton

Author: Mountzios Giannis   Dimopoulos Meletios-Athanassios   Bamias Aristotelis   Papadopoulos George   Kastritis Efstathios   Syrigos Konstantinos   Pavlakis George   Terpos Evangelos  

Publisher: Informa Healthcare

ISSN: 0284-186X

Source: Acta Oncologica, Vol.46, Iss.2, 2007-01, pp. : 221-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content